CASPOFUNGIN
Disclaimer: These predictions are for research purposes only. They do not constitute medical advice and require clinical validation.
Overview
| Property | Value |
|---|---|
| Drug Name | CASPOFUNGIN |
| DrugBank ID | DB00520 |
| HSA Status | Registered with Health Sciences Authority |
| KG Predictions | 25 |
| DL Predictions (≥0.7) | 50 |
Predicted Indications
The following indications are predicted based on TxGNN knowledge graph analysis:
| Indication | Source | Evidence |
|---|---|---|
| streptococcal infection | TxGNN Knowledge Graph | L5 |
| pneumonia caused by chlamydia | TxGNN Knowledge Graph | L5 |
| streptococcal pneumonia | TxGNN Knowledge Graph | L5 |
| mycoplasma pneumoniae pneumonia | TxGNN Knowledge Graph | L5 |
| chronic hepatitis c virus infection | TxGNN Knowledge Graph | L5 |
| hepatitis c virus infection | TxGNN Knowledge Graph | L5 |
| metastatic melanoma | TxGNN Knowledge Graph | L5 |
| pulmonary arterial hypertension | TxGNN Knowledge Graph | L5 |
| tuberous sclerosis | TxGNN Knowledge Graph | L5 |
| kidney angiomyolipoma | TxGNN Knowledge Graph | L5 |
Evidence Summary
External Resources
Generated by SgTxGNN on 2026-03-11